AOD-9604 AOD-9604 is a synthetic peptide derived from a fragment of human growth hormone (HGH)
Its GLP-1 receptor agonist portfolio, anchored by semaglutide in its injectable form (Ozempic for diabetes, Wegovy for obesity) and oral form (Rybelsus), generated approximately USD 26 billion in combined sales in 2024, making semaglutide the world's highest-revenue drug
NYK Last Week:12 Record: 35-25 OffRtg: 113.9 (16) DefRtg: 112.0 (7) NetRtg: +1.9 (12) Pace: 99.3 (21) The Raptors remain in fifth place in the East, continuing to take care of business against lesser opponents and coming up short against the better ones
Subcutaneous injection basics Use insulin syringes, typically 29-31 gauge with 0.5 inch needles
Frequently explored in advanced neurophysiological investigations
/ If you choose to supplement, look for liposomal formats